'Intrinsic value of Ranbaxy is very strong'

A day after Sun Pharma announced the decision to acquire Ranbaxy in an all-stock $4 billion deal, former promoters Malvinder Mohan Singh and Shivinder Mohan Singh share their views on the deal in an exclusive interaction with Business Today.